Relationship between polymorphisms of CYP 19 A 1 gene and hypertension : a meta-analysis
Yajie Meng,Dilare Adi,Ting Wang,Chunlan Dong,Bei Wang,Mayila Abudoukelimu,Fen Liu,Bangdang Chen,Zhenyan Fu,Yitong Ma
2017-01-01
Abstract:Objective and Background: Several published studies have investigated the relationship between the rs700518 and rs4646 polymorphisms in the CYP19A1 gene and the risk of hypertension; however, their results were inconsistent. To examine these inconclusive findings, we performed a meta-analysis to investigate the relationships between genetic polymorphisms of the CYP19A1 gene and the risk of hypertension. Methods: By searching PubMed, ISI Web of Science and Embase, as well as the Wanfang Database, the Chinese National Knowledge Infrastructure (CNKI) Database, the Weipu Database and the Chinese Academic Journal Full-text Database, we extracted data from eligible studies and included these data in our meta-analysis. The relationships between the rs700518 and rs4646 polymorphisms and hypertension were estimated using pooled odds ratios (ORs) and 95% confidence intervals (95% CIs). Heterogeneity was investigated and measured using Cochran’s Q test and the inconsistency index (I2) test. Meta-analysis was conducted using Review Manager Software (version 5.3). Results: A total of six studies from five articles including 1446 subjects with hypertension and 1658 healthy individuals were included in this meta-analysis. No relationship was found between the rs700518 and rs4646 polymorphisms in the CYP19A1 gene and the risk of hypertension (for rs700518, allele model: A vs. G, OR = 1.03, 95% CI: 0.93-1.13, P = 0.59; dominant model: AA vs. AG+GG, OR = 1.10, 95% CI: 0.95-1.27, P = 0.20; recessive: model: GG vs. AG+AA, OR = 1.04, 95% CI: 0.88-1.22, P = 0.65; for rs4646, allele model: G vs. T, OR = 1.00, 95% CI: 0.89-1.12, P = 0.98; GG vs. dominant model: GT+TT, OR = 1.02, 95% CI: 0.88-1.18, P = 0.80; recessive model: TT vs. GT+GG, OR = 0.97, 95% CI: 0.73-1.28, P = 0.83). However, if the data were stratified by gender (men and women), a relationship between the rs4646 polymorphism in the CYP19A1 gene and the risk of hypertension among female subjects under the recessive model (TT vs. GT+GG: P = 0.04) was found using a fixed-effect model. Conclusion: The results of our meta-analysis suggest that neither the rs700518 polymorphism nor the rs4646 polymorphism in the CYP19A1 gene is a genetic marker of hypertension susceptibility. Other factors, such as gender, appear to play a role in the relationship between the rs4646 polymorphism and the risk of hypertension.